Vancouver-based Cardiome has agreed to buy Artesian Therapeutics of Gaithersburg, Maryland. Artesian was formed three years ago to develop drugs for cardiovascular disease, sharing a research focus with Cardiome. Cardiome agreed to pay up to $32 million in milestone payments if Artesian's two drug leads reach a successful NDA. Also, Artesian's largest shareholder, Oxford BioScience Partners, will invest $7.5 million into Cardiome.
- read this AP story for more